| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_518cb6b546ef560ae890c2e5858647ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b908589854d8e32cb4517b94b98eb1e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57203c5774cb5d757373b08906d8f7d1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2011-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48d4117b7ddf414e3d387e45dfdc70d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be3fada70cc06da37c7ff2ea56dae2a1 |
| publicationDate |
2011-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011126010-A1 |
| titleOfInvention |
Cancer cell-specific cell-penetrating peptide and use thereof |
| abstract |
Disclosed are: a cancer cell-specific cell-penetrating peptide which comprises one of the amino acid sequences represented by SEQ ID NOS: 1-10 and has a cancer cell-specific membrane penetrating function; an antitumor agent that contains, as an active ingredient, an antitumor substance in which a peptide that has a cancer cell-specific membrane penetrating function is bonded with an antitumor factor; and an imaging agent having an ability of selectively accumulating in a tumor site, in which a peptide that has a cancer cell-specific membrane penetrating function is bonded with a labeling substance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013215104-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113694075-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017519041-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112843258-A |
| priorityDate |
2010-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |